One of the largest teams of statisticians and SAS programmers in Europe within a company is at your service, supporting the planning of your project, during the conduct or reporting phases with solutions that fit your needs:

The AMS  Biostatistics team has a long track record of successfully completed projects in a wide range of indications, from Phase I to IV, non-interventional projects, patient registries, epidemiological studies and outcomes research in projects for pharmaceuticals and medical devices, and for national and international projects.


Read more how AMS  Biostatistics services fit your needs!


Talk or write to us:



• 2022 – AMS are CTR- and MDR ready • 2022 – New unique AMS-ePRO® features launched • 2022 – Real-World Evidence focus in AMS Late-Stage Research • 2022 – AMS expanded its global reach • 2021 – DIGA dossier submission pioneer •